References
- Nagabhushan, T. L., Cooper, A. B., Tsai, H., Daniels, P. J. and Miller, G. H. : The syntheses biological properties of 1-N-(S-4-amino-2-bydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. J. Antibiot (Tokyo) 31, 681 (1978). https://doi.org/10.7164/antibiotics.31.681
- Tod, M., Padoin, C. and Petitjean, O. : Clinical pharmacokinetics and pharmacodynamics of isepamicin. Clin. Pharmacokinet. 38, 205 (2000). https://doi.org/10.2165/00003088-200038030-00002
- Barr, W. H., Colucci, R., Radwanski, E., Zampalione, N., Cutler, D., Lin, C. C., Elliott, M. and Affrime, M. B. : Pharmacokinetics of isepamicin. J. Chemother. 7, 53 (1995).
- Miller, G. H., Sabatelli, F. J., Naples, L., Hare, R. S. and Shaw, K. J. : The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin-a new broad-spectrum aminoglycoside. J. Chemother. 7, 31 (1995).
- Jones, R. N. : Isepamicin (SCH 21420, 1-N-HAPA Gentamicin B): microbiological characteristics including antimicrobial potency and spectrum of activity. J. Chemother. 7, 7 (1995).
- Uematsu, T., Mizuno, A., Suzuki, Y., Sato, R., Yamazaki, T. and Nakashima, M. : Evaluation of fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic. Ther. Drug. Monit. 10, 459 (1988). https://doi.org/10.1097/00007691-198804000-00014
- Tod, M., Minozzi, C., Beaucaire, G., Ponsonnet, D., Cougnard, T. and Petitjean, O. : Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study. J. Chemother. 44, 99 (1999).
- Radwanski, E., Batra, V., Korduba, C., Cayen, M., Cutler, D., Affrime, M., Nomeir, A. and Lin, C. C. : Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections. Antimicrob. Agent Chemother. 41, 1794 (1997).
- Nomeir, A. A., Radwanski, E., Cutler, D., Lin, C. C., Elliott, M., Affrime, M. B., Christopher, D., Korduba, C., Batra, V. and Cayen, M. N. : Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers. J. Clin. Pharmacol. 37, 1021 (1997). https://doi.org/10.1002/j.1552-4604.1997.tb04283.x
- Lin, C. C., Veals, J., Hilbert, M. J., Korduba, C. and Nomeir, A. A. : Analysis of isepamicin in humna plasma by radioimmunoassay, microbiologic assay, and high-performance liquid chromatography. Ther. Drug. Monit. 19, 675 (1997). https://doi.org/10.1097/00007691-199712000-00012
- Lin, C. C., Radwanski, E., Korduba, C., Affrime, M. and Cayen, M. : Pharmacokinetics of intramuscularly administered isepamicin in men. Antimicrob. Agent Chemother. 43, 86 (1997).
- Maloney, J. A. and Awni, W. M. L High-performance liquid chromatographic determination of isepamicin in plasma, urine and dialysate. J. Chemother. 526, 487 (1990).
- Vogel, R., DeFillipo, K. and Rief, V. : Determination of isepamicin sulfate and related compounds by high-performance liquid chromatography using evaporative light scattering detection. J. Pharm. Biomed. Anal. 24, 405 (2001). https://doi.org/10.1016/S0731-7085(00)00465-9
- Soltes, L. and Sebille, B. : A simple chiral high performance liquid chromatographic method to study the enantiomer differentiating action of microorganism. An assay with DLtryptophan. Biomed. Chromatogr. 13, 249 (1990).
- Hosokawa, S., Nakamura, K., Fujita, Y., Horiuchi, R. and Yamamoto, K. : Determination of isepamicin in human plasma by HPLC with fluorescence detection after derivatization using 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate. Biol. Pharm. Bull. 31, 1866 (2008). https://doi.org/10.1248/bpb.31.1866
- Kim, B. H., Kim, Y. K. and Ok, J. H. : Development of liquid chromatographic method for the analysis of kanamycin residues in varicella vaccine using phenylisocyanate as a derivatization reagent. J. Chromatogr. B. 752, 173 (2001). https://doi.org/10.1016/S0378-4347(00)00506-5
- Kim, B. H., Lee, S. C., Lee, H. J. and Ok, J. H. : Reversedphase liquid chromatographic method for the analysis of aminoglycoside antibiotics using pre-column derivatization with phenylisocyanate. Biomed. Chromatogr. 17, 396 (2003). https://doi.org/10.1002/bmc.254
- Lee, Y. J., Kim, Y. G., Lee, M. G., Chung, S. J., Lee, M. H. and Shim, C. K. : Analysis of bioequivalence study using logtransformed model, Yakhak Hoeji 44, 308 (2000).
- Tod, M., Padoin, C., Minozzi, C., Cougnard, J. and Petitjean, O. : Population pharmacokinetic study of isepamicin with intensive care unit patients, Antimicrob. Agent Chemother. 40, 983 (1996).